News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
CDC Director Delivers Passionate Speech to Agency
Jim Daley | Mar 30, 2018
Robert Redfield emphasized the importance of science and data in meeting with employees.
AIDS Researcher Emerges as Top Candidate to Head CDC
Ashley Yeager | Mar 19, 2018
Robert Redfield would replace Brenda Fitzgerald, who resigned in January over unresolved conflicts of interest.
Members of Presidential Advisory Council on HIV/AIDS Fired
Katarina Zimmer | Jan 3, 2018
The move follows mass resignations from the council in June.
Health Officials Agree Undetectable HIV Levels Likely Mean Uninfectious
Catherine Offord | Nov 26, 2017
Medical organizations endorse the “Undetectable = Untransmissible” campaign, which aims to raise awareness of scientific evidence showing that virally suppressed people living with HIV cannot infect others.
Scientists Look to Epigenetics to Thwart Viruses
Shawna Williams | Sep 1, 2017
Some viral pathogens modify chromatin and other epigenetic machinery, making them appealing drug targets.
Resistance to HIV Engineered Via CRISPR
Anna Azvolinsky | Aug 3, 2017
Mice transplanted with human hematopoietic stem cells that have an HIV receptor gene,
, disrupted by gene editing allows the animals to ward off HIV infection.
Child Lives with HIV for Years Without Treatments
Bob Grant | Jul 24, 2017
Another case of HIV remission emerges, this time in a South African girl diagnosed as an infant and disease-free for more than eight years.
Immunized Cows Produce Anti-HIV Antibodies
Jef Akst | Jul 20, 2017
Cows injected with a protein that mimics HIV’s envelope make broadly neutralizing antibodies that inhibit multiple strains of the virus.
Demonstrating Discontent, May 21, 1990
Andrea Anderson | Jul 17, 2017
Activists demanded greater access to and involvement in clinical research for AIDS treatments—and their protests were heard.
Study: New Test Can Unearth Elusive HIV
Aggie Mika | May 29, 2017
The assay screens for latent virus that has the capacity to activate if antiretroviral therapy stops.